Advanced Solid Tumors with KRAS G12C Mutation
People with Advanced Solid Tumors with KRAS G12C Mutation are asked to participate in a research study being conducted by Monter Cancer Center.
You may be eligible to participate in this study if you:
• Are a male or female at least 18 years of age
• Have histologically confirmed diagnosis of a solid tumor malignancy
• Have presence of tumor lesions
You may NOT participate in this study if you:
• Have active brain metastases
• Have undergone major surgery within 4 weeks of first dose date
• Have carcinomatous meningitis
• Have a history of stroke or transient ischemic attack
• Have known immunodeficiency virus (HIV) infection, hepatitis B, or C
• Are pregnant or breastfeeding
Contact Information
Alexa Amoroso, Study Coordinator
450 Lakeville Road, Lake Success, NY 11042
Phone: (516) 734-8977
Email: AAMOROSO1@NORTHWELL.EDU